Enhancing curcumin anticancer efficacy through di-block copolymer micelle encapsulation

Journal of Biomedical Nanotechnology

Volumn 10, Issue 2, 2014, Pages 179-193

  Lv, Li ^a   Shen, Yuanyuan ^a   Liu, Jieying ^a   Wang, Feihu ^a   Li, Min ^a   Li, Mingna ^a   Guo, Aijie ^a   Wang, Yun ^a   Zhou, Dejian ^b   Guo, Shengrong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Biodistribution; Block copolymer micelle; Cancer therapy; Curcumin; Nanomedicine

Indexed keywords

BIOCHEMISTRY; BIOCOMPATIBILITY; BLOCK COPOLYMERS; CELL CULTURE; CELL DEATH; DISEASES; DRUG PRODUCTS; LACTIC ACID; MAMMALS; MEDICAL NANOTECHNOLOGY; MOLECULAR BIOLOGY; ONCOLOGY; POLYETHYLENE GLYCOLS; TUMORS;

ANTI-TUMOR ACTIVITIES; BIODISTRIBUTIONS; BLOCK CO-POLYMER MICELLES; CANCER THERAPY; CURCUMIN; DI-BLOCK COPOLYMERS; POLY L LACTIC ACID; TARGETED CANCER THERAPY;

MICELLES;

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CURCUMIN; MACROGOL DERIVATIVE; POLYESTER; POLYMER;

ANIMAL; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECT; ENDOCYTOSIS; FEMALE; FLUORESCENCE; HELA CELL; HUMAN; HYDRODYNAMICS; IC 50; MICELLE; MOUSE; NEOPLASM; PARTICLE SIZE; PATHOLOGY; TISSUE DISTRIBUTION; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT OUTCOME;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DEATH; CELL PROLIFERATION; CURCUMIN; ENDOCYTOSIS; FEMALE; FLUORESCENCE; HELA CELLS; HUMANS; HYDRODYNAMICS; INHIBITORY CONCENTRATION 50; MICE; MICELLES; MICROSCOPY, ELECTRON, TRANSMISSION; NEOPLASMS; PARTICLE SIZE; POLYESTERS; POLYETHYLENE GLYCOLS; POLYMERS; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

EID: 84988531206     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2014.1809     Document Type: Article

References (46)

1. R. K. Maheshwari, A. K. Singh, J. Gaddipati, and R. C. Srimal, Multiple biological activities of curcumin: A short review. Life Sci. 78, 2081 (2006).
2. S. M. Oliveira, I. F. Amaral, M. A. Barbosa, and C. C. Teixeira, Engineering endochondral bone: In vitro studies. Tissue Eng. Part A 15, 625 (2009).
3. L. Song, Y. Shen, J. Hou, L. Lei, S. Guo, and C. Qian, Polymeric micelles for parenteral delivery of curcumin: Preparation, characterization and in vitro evaluation. Colloid Surf. A-Physicochem. Eng. Asp. 390, 25 (2011).
4. G. Guo, S. Fu, L. Zhou, H. Liang, M. Fan, F. Luo, Z. Qian, and Y. Wei, Preparation of curcumin loaded poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) nanofibers and their in vitro antitumor activity against Glioma 9L cells. Nanoscale 3, 3825 (2011).
5. M. M. Yallapu, M. Jaggi, and S. C. Chauhan, Curcumin nanoformulations: A future nanomedicine for cancer. Drug Discov. Today 17, 71 (2012).
6. F. Akhtar, M. Rizvi, and S. K. Kar, Oral delivery of curcumin bound to chitosan nanoparticles cured Plasmodium yoelii infected mice. Biotechnol. Adv. 30, 310 (2012).
7. L. Li, B. Ahmed, K. Mehta, and R. Kurzrock, Liposomal curcumin with and without oxaliplatin: Effects on cell growth, apoptosis, and angiogenesis in colorectal cancer. Mol. Cancer Ther. 6, 1276 (2007).
8. C. Gong, S. Deng, Q. Wu, M. Xiang, X. Wei, L. Li, X. Gao, B. Wang, L. Sun, Y. Chen, Y. Li, L. Liu, Z. Qian, and Y. Wei, Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles. Biomaterials 34, 1413 (2013).
9. M. L. Gou, K. Men, H. S. Shi, M. L. Xiang, J. Zhang, J. Song, J. L. Long, Y. Wan, F. Luo, and X. Zhao, Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale 3, 1558 (2011).
10. A. Safavy, K. P. Raisch, S. Mantena, L. L. Sanford, S. W. Sham, N. R. Krishna, and J. A. Bonner, Design and development of watersoluble curcumin conjugates as potential anticancer agents. J. Med. Chem. 50, 6284 (2007).
11. P. Anand, A. B. Kunnumakkara, R. A. Newman, and B. B. Aggarwal, Bioavailability of curcumin: Problems and promises. Mol. Pharm. 4, 807 (2007).
12. A. S. Jain, S. M. Shah, M. S. Nagarsenker, Y. Nikam, R. P. Gude, F. Steiniger, J. Thamm, and A. Fahr, Lipid colloidal carriers for improvement of anticancer activity of orally delivered quercetin: Formulation, characterization and establishing in vitro in vivo advantage. J. Biomed. Nanotechnol. 9, 1230 (2013).
13. A. L. Miranda-Vilela, R. C. A. Peixoto, J. P. F. Longo, F. A. Portilho, K. L. C. Miranda, P. P. C. Sartoratto, S. N. Bao, R. B. De Azevedo, and Z. G. M. Lacava, Dextran-functionalized magnetic fluid mediating magnetohyperthermia combined with preventive antioxidant pequi-oil supplementation: Potential use against cancer. J. Biomed. Nanotechnol. 9, 1261 (2013).
14. K.-J. Lee, J. H. An, J.-R. Chun, K.-H. Chung, W.-Y. Park, J.-S. Shin, D.-H. Kim, and Y. Y. Bahk, In vitro analysis of the anti-cancer activity of mitoxantrone loaded on magnetic nanoparticles. J. Biomed. Nanotechnol. 9, 1071 (2013).
15. G. Zhang, X. Zeng, and P. Li, nanomaterials in cancer-therapy drug delivery system. J. Biomed. Nanotechnol. 9, 741 (2013).
16. C. A. Dehelean, S. Feflea, D. Gheorgheosu, S. Ganta, A. M. Cimpean, D. Muntean, and M. M. Amiji, Anti-angiogenic and anticancer evaluation of betulin nanoemulsion in chicken chorioallantoic membrane and skin carcinoma in balb/c mice. J. Biomed. Nanotechnol. 9, 577 (2013).
17. Q. Long, Y. Xie, Y. Huang, Q. Wu, H. Zhang, S. Xiong, Y. Liu, L. Chen, Y. Wei, and X. Zhao, Induction of apoptosis and inhibition of angiogenesis by pegylated liposomal quercetin in both cisplatin-sensitive and cisplatin-resistant ovarian cancers. J. Biomed. Nanotechnol. 9, 965 (2013).
18. M. Sharma, R. Malik, A. Verma, P. Dwivedi, G. S. Banoth, N. Pandey, J. Sarkar, P. R. Mishra, and A. K. Dwivedi, Folic acid conjugated guar gum nanoparticles for targeting methotrexate to colon cancer. J. Biomed. Nanotechnol. 9, 96 (2013).
19. A. Gupta, S. Asthana, R. Konwar, and M. Chourasia, An insight into potential of nanoparticles-assisted chemotherapy of cancer using gemcitabine and its fatty acid prodrug: a comparative study. J. Biomed. Nanotechnol. 9, 915 (2013).
20. V. Saxena and M. D. Hussain, Polymeric mixed micelles for delivery of curcumin to multidrug resistant ovarian cancer. J. Biomed. Nanotechnol. 9, 1146 (2013).
21. M. E. Davis, Nanoparticle therapeutics: An emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7, 771 (2008).
22. M. L. Adams, A. Lavasanifar and G. S. Kwon, Amphiphilic block copolymers for drug delivery. J. Pharm. Sci. 92, 1343 (2003).
23. Z. He, Y. Yu, Y. Zhang, Y. Yan, Y. Zheng, J. He, Y. Xie, G. He, Y. Wei, and X. Song, Gene delivery with active targeting to ovarian cancer cells mediated by folate receptor. J. Biomed. Nanotechnol. 9, 833 (2013).
24. L. Lv, Y. Shen, M. Li, X. Xu, M. Li, S. Guo, and S. Huang, Preparation and in vitro evaluation of novel poly(anhydride-ester)-based amphiphilic copolymer curcumin-loaded micelles. J. Biomed. Nanotechnol. 10, 1 (2014).
25. J. Mönkäre, R. A. Hakala, M. A. Vlasova, A. Huotari, M. Kilpeläinen, A. Kiviniemi, V. Meretoja, K. H. Herzig, H. Korhonen, J. V. Seppälä, and K. Järvinen, Biocompatible photocrosslinked poly(ester anhydride) based on functionalized poly([epsilon]-caprolactone) prepolymer shows surface erosion controlled drug release in vitro and in vivo. J. Controlled Release 146, 349 (2010).
26. R. A. Hakala, H. Korhonen, V. V. Meretoja, and J. V. Seppä Lä, Photo-cross-linked biodegradable poly(ester anhydride) networks prepared from alkenylsuccinic anhydride functionalized poly(ϵcaprolactone) precursors. Biomacromolecules 12, 2806 (2011).
27. Y. Wang, C. Wang, C. Gong, Y. Wang, G. Guo, F. Luo, and Z. Qian, Polysorbate 80 coated poly(-caprolactone)-poly(ethylene glycol)-poly(-caprolactone) micelles for paclitaxel delivery. Int. J. Pharm. 434, 1 (2012).
28. H. S. Choi, W. Liu, P. Misra, E. Tanaka, J. P. Zimmer, B. I. Ipe, M. G. Bawendi, and J. V. Frangioni, Renal clearance of quantum dots. Nat. Biotechnol. 25, 1165 (2007).
29. D. Peer, J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit, and R. Langer, Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751 (2007).
30. M. J. Santander-Ortega, N. Csaba, L. González, D. Bastos-González, J. L. Ortega-Vinuesa, and M. J. Alonso, Protein-loaded PLGA-PEO blend nanoparticles: Encapsulation, release and degradation characteristics. Colloid Polym. Sci. 288, 141 (2010).
31. H. Xin, X. Jiang, J. Gu, X. Sha, L. Chen, K. Law, Y. Chen, X. Wang, Y. Jiang, and X. Fang, Angiopep-conjugated poly(ethylene glycol)-co-poly([epsilon]-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Biomaterials 32, 4293 (2011).
32. P. L. Soo, L. Luo, D. Maysinger, and A. Eisenberg, Incorporation and release of hydrophobic probes in biocompatible polycaprolactone-block-poly(ethylene oxide) micelles: Implications for drug delivery. Langmuir 18, 9996 (2002).
33. R. Misra and S. K. Sahoo, Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy. Eur. J. Pharm. Sci. 39, 152 (2010).
34. M. Li, W. Song, Z. Tang, S. Lv, L. Lin, H. Sun, Q. Li, Y. Yang, H. Hong, and X. Chen, Nanoscaled poly(l-glutamic acid)/doxorubicin-amphiphile complex as pH-responsive drug delivery system for effective treatment of nonsmall cell lung cancer. Acs Appl. Mater. Interfaces 5, 1781 (2013).
35. J. Chang, Y. Li, G. Wang, B. He, and Z. Gu, Fabrication of novel coumarin derivative functionalized polypseudorotaxane micelles for drug delivery. Nanoscale 5, 813 (2013).
36. A. Kunwar, A. Barik, B. Mishra, K. Rathinasamy, R. Pandey, and K. Priyadarsini, Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and tumor cells. BBA-General Subjects 1780, 673 (2008).
37. H. Tang, C. J. Murphy, B. Zhang, Y. Shen, E. A. Van Kirk, W. J. Murdoch, and M. Radosz, Curcumin polymers as anticancer conjugates. Biomaterials 31, 7139 (2010).
38. S.-D. Li and L. Huang, Stealth nanoparticles: High density but sheddable PEG is a key for tumor targeting. J. Control. Release 145, 178 (2010).
39. P. Carmeliet and R. K. Jain, Angiogenesis in cancer and other diseases. Nature 407, 249 (2000).
40. S. W. Chung, M. Lee, S. M. Bae, J. Park, O. C. Jeon, H. S. Lee, H. Choe, H. S. Kim, B. S. Lee, and R.-W. Park, Potentiation of anti-angiogenic activity of heparin by blocking the ATIII-interacting pentasaccharide unit and increasing net anionic charge. Biomaterials 35, 9070 (2012).
41. J. Duan, Y. Zhang, S. Han, Y. Chen, B. Li, M. Liao, W. Chen, X. Deng, J. Zhao, and B. Huang, Synthesis and in vitro/in vivo anticancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles. Int. J. Pharm. 400, 211 (2010).
42. A. Cheng, H. Chan, K. F. To, W. K. Leung, K. K. Chan, C. T. Liew, and J. Sung, Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma. Int. J. Oncol. 24, 853 (2004).
43. A. L. Cheng, C. H. Hsu, J. K. Lin, M. M. Hsu, Y. F. Ho, T. S. Shen, J. Y. Ko, J. T. Lin, B. R. Lin, and W. Ming-Shiang, Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer. Res. 21, 2895 (2001).
44. C. D. Lao, M. T. Ruffin, D. Normolle, D. D. Heath, S. I. Murray, J. M. Bailey, M. E. Boggs, J. Crowell, C. L. Rock, and D. E. Brenner, Dose escalation of a curcuminoid formulation. BMC complement. Altern. Med. 6, 6 (2006).
45. W. She, N. Li, K. Luo, C. Guo, G. Wang, Y. Geng, and Z. Gu, Dendronized heparin-doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy. Biomaterials 34, 2252 (2013).
46. S.-D. Li and L. Huang, Pharmacokinetics and biodistribution of nanoparticles. Mol. Pharm. 5, 496 (2008).